Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan
Clinical trial NCT02977312 · COMPLETED
Trial details
- NCT number
- NCT02977312
- Sponsor
- Hikma Pharmaceuticals LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-08-01
- Primary completion
- 2015-02-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.